[ad_1] BEIJING: Most newly discharged patients who recently recovered from COVID-19 produces varying virus-specific antibodies and T cells, according to a study that has implications for designing an effective vaccine against the deadly disease. Fourteen patients examined in the study, published in the journal Immunity, showed wide-ranging immune responses. However, …
Read More »